⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2006809 | 1.00 | — | — | |
| SCHEMBL6128497 | 1.00 | — | — | |
| SCHEMBL26402549 | 0.85 | — | — | |
| SCHEMBL16659519 | 0.82 | CYP1A2 (0.36) | — | |
| SCHEMBL12074489 | 0.81 | KDM4E (0.36) | — | |
| SCHEMBL18573248 | 0.80 | CYP1A2 (0.35) | — | |
| SCHEMBL18576605 | 0.80 | CYP1A2 (0.35) | — | |
| SCHEMBL18576891 | 0.80 | CYP1A2 (0.35) | — | |
| SCHEMBL8344135 | 0.74 | KDM4E (0.32) | — | |
| SCHEMBL18372673 | 0.74 | ATM (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139879-A1 | QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | AstraZeneca AB (SE) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008114002-A1 | QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | ASTRAZENECA AB (SE) | 2008-09-25 | — | — | WO | disclosed |
| US-20070275953-A1 | 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties | FACULTES UNIVERSITAIRES NOTRE-DAME DE LA PAIX (BE) | 2007-11-29 | — | — | US | disclosed |
| US-20070275953-A1 | 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties | FACULTES UNIVERSITAIRES NOTRE-DAME DE LA PAIX (BE) | 2007-11-29 | — | — | US | disclosed |